Back to Search
ARUN GUPTA, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1962444802Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
161794(NY)
Research & Publications (20)
The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
PMID 19438818·J Eur Acad Dermatol Venereol·2009
2-rct
Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis.
PMID 18459518·J Drugs Dermatol·2008
1-meta
Antibodies against G-protein coupled receptors: novel uses in screening and drug development.
PMID 18673273·Comb Chem High Throughput Screen·2008
6-review
Role of protein C in renal dysfunction after polymicrobial sepsis.
PMID 17301189·J Am Soc Nephrol·2007
7-preclinical
Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay.
PMID 17714569·Br J Dermatol·2007
8-other
The use of receptor-specific antibodies to study G-protein-coupled receptors.
PMID 16878273·Mt Sinai J Med·2006
7-preclinical
Targeting opioid receptor heterodimers: strategies for screening and drug development.
PMID 16584123·AAPS J·2006
6-review
Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
PMID 17062029·J Eur Acad Dermatol Venereol·2006
4-observational
Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.
PMID 16426382·Int J Dermatol·2006
4-observational
Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
PMID 15679072·J Pediatr Endocrinol Metab·2005
8-other
Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
PMID 16502198·J Cutan Med Surg·2005
4-observational
Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective.
PMID 16292454·Skin Therapy Lett·2005
6-review
A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
PMID 15987289·J Eur Acad Dermatol Venereol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1703 MERRICK AVE
MERRICK, NY 11566 - Phone
- (516) 378-3311
Quick Facts
- NPI
- 1962444802
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile